Search Results for "Anemia Incidence Breast Cancer"
Original Source: Incidence of anemia, leukocytosis, and thrombocytosis in patients with solid tumors in China.
Despite the fact that malignancies are associated with hematological abnormalities, some clinical studies have been unable to detect such a relation. The aim of our study was to detect the prevalence of pretreatment hematologic abnormalities in patients with common solid tumors and to determine if such a profile could be used for prognostic evaluations. We identified all patients in Cancer Center of Sun Yat-sen University who were diagnosed as solid tumors (breast carcinoma, hepatocellular carcinoma, nasoph...
Matching Channels
Breast cancer in the UK is diagnosed in nearly 46,000 people each year, with just over 12,000 dying from breast cancer each year in he UK. There are several risk factors for developing b...
Epithelial cell adhesion molecule EpCAM CD326
Epithelial cell adhesion molecule (EpCAM; CD326) is a cell surface protein that is frequently expressed at high level on most solid tumor types, including prostate, breast, colon, gastric, ovarian,...
Selective Estrogen Receptor Modulators SERMs
Selective estrogen receptor modulators (SERMs) act as estrogen receptor (ER) agonists or antagonist depending on the targeted tissue and the specific configuration of the used SERM. Effects on bone, e...
Cervical cancer is a malignant neoplasm of the cervix uteri or cervical area. Symptoms include vaginal bleeding, but may not present until later stages of the cancer. Cervical cancer can be treated...
Matching News
Anemia: A Manageable Side Effect Skin Cancer
Anemia, one of the most common side effects associated with cancer, affects over 60 percent of cancer patients. Anemia may occur as either a direct result of the cancer or, more commonly, as a side ef...
Density Of Breasts Does Not Impact Death Among Breast Cancer Patients
A study featured in the August 20 edition in the Journal of the National Cancer Institute reveals that the risk of mortality from breast cancer is not associated with high mammographic breast density...
Treating HER2+ Breast Cancer With HIV Drug
The HIV protease inhibitor, Nelfinavir, can be used to treat HER2-positive breast cancer in the same capacity and dosage regimen that it is used to treat HIV, according to a study published in the Jou...
Breast cancer… do you know who diagnoses you?
Australian women have a 1 in 9 lifetime risk of developing breast cancer and 1 in every 100 breast cancers occurs in men. In 2012, it is estimated that 14,610 women will be diagnosed with breast canc...
Breast augmentation may hurt breast cancer survival
The weight of evidence from epidemiological studies indicates cosmetic breast implants are not associated with increased risk of breast cancer, but concern remains because implants may impair the ab...
Breast Implants Linked to Poorer Survival From Breast Cancer
Women with breast implants who develop breast cancer have a higher risk of being diagnosed with nonlocalized breast tumors and lower breast-cancer-specific survival, but there are study limitations....
(Broad Institute of MIT and Harvard) Breast cancer is not a single disease, but a collection of diseases with dozens of different mutations that crop up with varying frequency across different breast...
My battle with breast cancer: Diet and exercise
Being overweight adds to your risk of getting breast cancer. It also increases your risk of recurring breast cancer. The problem is that chemo, medications and dealing with cancer suck the energy out...
Matching PubMed Articles
Abstract Purpose. To evaluate the effects of epoetin alfa on patient-reported outcomes (PROs) in patients with breast cancer receiving myelotoxic chemotherapy. Materials and Methods. Women with hemogl...
A portion of familial breast cancer cases are caused by mutations in the same genes that are inactivated in the downstream part of Fanconi anemia (FA) signaling pathway. Here we have assessed the FANC...
PALB2/FANCN: Recombining Cancer and Fanconi Anemia.
Partner and localizer of BRCA2 (PALB2) was originally identified as a BRCA2-interacting protein that is crucial for key BRCA2 genome caretaker functions. It subsequently became clear that PALB2 was an...
It has been reported that one biallelic missense mutation in the RAD51C gene was found in a Fanconi anemia-like disorder and six monoallelic pathogenic mutations were identified in 480 BRCA1/2 negativ...
PURPOSE: Lung cancers account for 5 % of second primary cancers after breast cancer. The low overall 5-year relative survival rate of lung cancer makes it a particularly concerning new malignancy for...
